Bonvalot, Sylvie
Institut Curie,
France
2024 Rank: 63675
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 2063 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63675 | 55472 |
| Total Cites | 1599 | 2105 |
| H-index | 20 | 23 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 233 | 288 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 428 | 531 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 954 | 1103 |
| Ratio of Total Citations to Distinct Citing Papers | 1.68 | 1.91 |
| Self-Citation Percentage |
24.04%
|
|
Bonvalot, Sylvie
Institut Curie,
France
2023 Rank: 83814
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 3029 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83814 | 75901 |
| Total Cites | 1401 | 1787 |
| H-index | 20 | 23 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 203 | 236 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 372 | 442 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 879 | 1011 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.77 |
| Self-Citation Percentage |
21.60%
|
|
Bonvalot, Sylvie
Institut Curie,
France
2022 Rank: 94382
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 3575 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94382 | 87891 |
| Total Cites | 1154 | 1520 |
| H-index | 18 | 20 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 179 | 220 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 317 | 393 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 774 | 911 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.67 |
| Self-Citation Percentage |
24.08%
|
|
Bonvalot, Sylvie
Institut Curie,
France
2021 Rank: 121848
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Surgery
Rank in SubField 1: 4350 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121848 | 104868 |
| Total Cites | 1559 | 2070 |
| H-index | 21 | 25 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 211 | 265 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 413 | 519 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1055 | 1246 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.66 |
| Self-Citation Percentage |
24.69%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.